Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL1706 + Chemotherapy for Perioperative Treatment of NSCLC
NCT07452003Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2028
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of QL1706 in non-small cell lung cancer (NSCLC), sponsored by Peking Union Medical College Hospital. Started Jan 2026; status: recruiting.
02
Drugs
QL1706
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07452003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07452003.